The Cooper Companies, Inc. (NASDAQ:COO) Stock Has Consensus Price Target of $68.60

Key Points

• Analysts maintain a “Hold” consensus on Cooper Companies, with 13 hold, four buy and two sell ratings among 19 brokerages. The average 12-month price target is $68.60, versus a recent share price of $59.12.
• Company directors purchased a combined 17,000 shares in September, while insiders bought 34,701 shares worth approximately $1.88 million over the past three months. Institutional investors and hedge funds own 24.39% of the company.
• Cooper Companies slightly exceeded quarterly EPS expectations, reporting $1.15 versus the $1.12 consensus, although revenue of $1.07 billion came below estimates. The board also authorized a $3 billion stock repurchase plan, covering up to 22.7% of outstanding shares.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) has earned an average rating of "Hold" from the nineteen brokerages that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation and four have given a buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $68.60.

A number of equities research analysts have issued reports on the stock. Robert W. Baird set a $61.00 price objective on shares of Cooper Companies and gave the stock a "neutral" rating in a research note on Thursday, September 10th. Needham & Company LLC dropped their target price on shares of Cooper Companies from $86.00 to $73.00 and set a "buy" rating for the company in a research report on Thursday, September 10th. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $71.00 to $58.00 and set a "neutral" rating for the company in a report on Thursday, September 10th. Weiss Ratings raised shares of Cooper Companies from a "sell (d)" rating to a "hold (c-)" rating in a report on Friday, September 18th. Finally, Mizuho set a $75.00 price target on shares of Cooper Companies and gave the stock an "outperform" rating in a research report on Thursday, September 10th.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Lawrence Kurzius bought 10,000 shares of the business's stock in a transaction on Monday, September 14th. The stock was purchased at an average cost of $53.91 per share, for a total transaction of $539,100.00. Following the completion of the purchase, the director directly owned 21,099 shares of the company's stock, valued at approximately $1,137,447.09. This trade represents a 90.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Walter Rosebrough, Jr. bought 7,000 shares of Cooper Companies stock in a transaction on Friday, September 11th. The stock was acquired at an average cost of $54.11 per share, for a total transaction of $378,770.00. Following the acquisition, the director owned 17,000 shares in the company, valued at approximately $919,870. This represents a 70.00% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 34,701 shares of company stock worth $1,880,039 over the last three months. Corporate insiders own 2.08% of the company's stock.

Hedge Funds Weigh In On Cooper Companies

A number of institutional investors have recently modified their holdings of COO. Nisa Investment Advisors LLC grew its holdings in shares of Cooper Companies by 84.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 192,454 shares of the medical device company's stock valued at $10,879,000 after purchasing an additional 88,216 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its position in Cooper Companies by 834.6% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 112,677 shares of the medical device company's stock worth $6,370,000 after purchasing an additional 100,621 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in Cooper Companies by 84.0% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 52,747 shares of the medical device company's stock worth $2,982,000 after purchasing an additional 24,084 shares in the last quarter. TD Waterhouse Canada Inc. acquired a new position in Cooper Companies during the 3rd quarter worth approximately $2,669,000. Finally, Trail Ridge Investment Advisors LLC lifted its stake in Cooper Companies by 17.1% in the 3rd quarter. Trail Ridge Investment Advisors LLC now owns 12,293 shares of the medical device company's stock valued at $695,000 after purchasing an additional 1,793 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Performance

COO opened at $59.12 on Wednesday. The firm has a market cap of $11.24 billion, a P/E ratio of 20.18, a price-to-earnings-growth ratio of 2.37 and a beta of 0.83. Cooper Companies has a 52-week low of $51.01 and a 52-week high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22. The business's fifty day moving average is $62.74 and its 200-day moving average is $65.94.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.12 by $0.03. The company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. Cooper Companies's revenue was up .5% on a year-over-year basis. During the same quarter last year, the business earned $0.49 earnings per share. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Sell-side analysts expect that Cooper Companies will post 4.53 EPS for the current fiscal year.

Cooper Companies declared that its Board of Directors has approved a stock repurchase plan on Wednesday, September 9th that permits the company to repurchase $3.00 billion in shares. This buyback authorization permits the medical device company to buy up to 22.7% of its shares through open market purchases. Stock buyback plans are usually a sign that the company's management believes its stock is undervalued.

About Cooper Companies

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women's health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women's health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.